United States Pharmaceuticals

Eagle Pharmaceuticals Inc (EGRX)

Track

Track

Ticker: EGRX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Eagle Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
195.21
Quantity 12,838 -31.8%
Value US$351,884
3.4
Tarriff Scott CEO and President
Transaction date
Proposed sale
Price
345.39
Quantity 4,681
Value US$1,583,049
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
309.49
Quantity 17,619 -42.0%
Value US$1,128,849
3.4
Tarriff Scott CEO and President
Transaction date
Proposed sale
Price
13.73
Quantity 10,925
Value US$150,000
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
15.11
Quantity 710 -0.1%
Value US$10,728
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
14.41
Quantity 10,024 -1.7%
Value US$144,446
3.4
Tarriff Scott CEO and President
Transaction date
Proposed sale
Price
14.44
Quantity 10,734
Value US$155,000
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
15.23
Quantity 9,511 -1.6%
Value US$144,853
3.4
Tarriff Scott CEO and President
Transaction date
Proposed sale
Price
15.77
Quantity 9,511
Value US$150,000
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Sale
Price
19.98
Quantity 15,000 -2.5%
Value US$299,700
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Sale
Price
21.52
Quantity 200 -0.0%
Value US$4,304
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Sale
Price
21.06
Quantity 14,800 -0.9%
Value US$311,688
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Sale
Price
20.42
Quantity 11,869 -0.7%
Value US$242,365
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Sale
Price
19.69
Quantity 3,131 -0.2%
Value US$61,649
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Sale
Price
20.71
Quantity 15,000 -0.9%
Value US$310,650
3.4
Tarriff Scott CEO and President
Transaction date
Proposed sale
Price
20.83
Quantity 60,000
Value US$1,250,000
2.2
Edlin Richard A. Non-Executive Director
Transaction date
Sale
Price
30.99
Quantity 6,800 -23.1%
Value US$210,732
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
50.15
Quantity 24,975 -1.6%
Value US$1,252,496
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
51.81
Quantity 12,428 -0.8%
Value US$643,895
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
50.51
Quantity 12,000 -0.8%
Value US$606,120
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
42.30
Quantity 900 -0.1%
Value US$38,070
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
41.52
Quantity 29,185 -1.8%
Value US$1,211,761
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
40.57
Quantity 302 -0.0%
Value US$12,252
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
39.70
Quantity 5,670 -0.4%
Value US$225,099
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
39.04
Quantity 10,597 -0.7%
Value US$413,707
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
40.03
Quantity 8,500 -0.6%
Value US$340,255
3.4
Tarriff Scott CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
39.30
Quantity 6,500 -0.4%
Value US$255,450
FLAUM SANDER A Non-Executive Director
Transaction date
Sale
Price
53.94
Quantity 2,340 -17.1%
Value US$126,220
Meyers Pete A. Chief Financial Officer
Transaction date
Purchase
Price
55.45
Quantity 350 +100.0%
Value US$19,406
Braunstein Douglas L
Transaction date
Purchase
Price
50.09
Quantity 1,584 +0.2%
Value US$79,338
Braunstein Douglas L
Transaction date
Purchase
Price
49.21
Quantity 15,206 +1.6%
Value US$748,258
Braunstein Douglas L
Transaction date
Purchase
Price
48.06
Quantity 3,610 +0.4%
Value US$173,490
Meyers Pete A. Chief Financial Officer
Transaction date
Purchase
Price
71.49
Quantity 350 +inf%
Value US$25,021
Pernock David Pres. & Chief Comm. Officer Officer
Transaction date
Purchase
Price
79.69
Quantity 255 +35.9%
Value US$20,321
Pernock David Pres. & Chief Comm. Officer Officer
Transaction date
Purchase
Price
82.24
Quantity 200 +39.1%
Value US$16,448
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
89.09
Quantity 2,961 -30.4%
Value US$263,795
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
88.34
Quantity 51,219 -84.0%
Value US$4,524,686
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.13
Quantity 61,420 -1.7%
Value US$5,105,845
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.02
Quantity 23,689 -0.6%
Value US$1,966,661
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.00
Quantity 6,223 -0.2%
Value US$516,509
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.01
Quantity 1,600 -6.4%
Value US$132,816
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.01
Quantity 500 -6.9%
Value US$41,505
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.01
Quantity 58,755 -1.6%
Value US$4,877,253
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.02
Quantity 6,182 -0.2%
Value US$513,230
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.00
Quantity 1,300 -5.0%
Value US$107,900
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.00
Quantity 400 -5.2%
Value US$33,200
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.00
Quantity 37,731 -1.0%
Value US$3,131,673
Krill Steven L. EVP & Chief Scientific Officer
Transaction date
Sale
Price
82.06
Quantity 7,025 -100.0%
Value US$576,489
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.01
Quantity 700 -0.0%
Value US$58,107
Krill Steven L. EVP & Chief Scientific Officer
Transaction date
Sale
Price
80.09
Quantity 7,100 -100.0%
Value US$568,641
Edlin Richard A.
Transaction date
Purchase
Price
79.44
Quantity 6,000 +25.6%
Value US$476,640
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
83.10
Quantity 500 -0.0%
Value US$41,550
Pernock David Pres. & Chief Comm. Officer
Transaction date
Purchase
Price
83.98
Quantity 61 +13.6%
Value US$5,123
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
82.10
Quantity 51,883 -1.4%
Value US$4,259,594
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
82.01
Quantity 38,997 -1.0%
Value US$3,198,144
ProQuest Investments IV, L.P. Large shareholder
Transaction date
Sale
Price
82.08
Quantity 9,120 -0.2%
Value US$748,570
Pernock David Pres. & Chief Comm. Officer
Transaction date
Purchase
Price
77.84
Quantity 450 +inf%
Value US$35,028
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-11-03 2023-11-02 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
12,838 -31.8%
195.21
US$351,884 		12,838 -31.8% 195.21 US$351,884
2023-11-02 2023-11-02 PrS Proposed sale
3.4
Tarriff Scott

CEO and President
4,681
345.39
US$1,583,049 		4,681 345.39 US$1,583,049
2023-11-03 2023-11-01 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
17,619 -42.0%
309.49
US$1,128,849 		17,619 -42.0% 309.49 US$1,128,849
2023-11-01 2023-11-01 PrS Proposed sale
3.4
Tarriff Scott

CEO and President
10,925
13.73
US$150,000 		10,925 13.73 US$150,000
2023-10-04 2023-10-03 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
710 -0.1%
15.11
US$10,728 		710 -0.1% 15.11 US$10,728
2023-10-04 2023-10-03 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
10,024 -1.7%
14.41
US$144,446 		10,024 -1.7% 14.41 US$144,446
2023-10-03 2023-10-03 PrS Proposed sale
3.4
Tarriff Scott

CEO and President
10,734
14.44
US$155,000 		10,734 14.44 US$155,000
2023-10-04 2023-10-02 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
9,511 -1.6%
15.23
US$144,853 		9,511 -1.6% 15.23 US$144,853
2023-10-02 2023-10-02 PrS Proposed sale
3.4
Tarriff Scott

CEO and President
9,511
15.77
US$150,000 		9,511 15.77 US$150,000
2023-05-18 2023-05-16 S Sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
15,000 -2.5%
19.98
US$299,700 		15,000 -2.5% 19.98 US$299,700
2023-05-15 2023-05-15 S Sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
200 -0.0%
21.52
US$4,304 		200 -0.0% 21.52 US$4,304
2023-05-15 2023-05-15 S Sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
14,800 -0.9%
21.06
US$311,688 		14,800 -0.9% 21.06 US$311,688
2023-05-15 2023-05-12 S Sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
11,869 -0.7%
20.42
US$242,365 		11,869 -0.7% 20.42 US$242,365
2023-05-15 2023-05-12 S Sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
3,131 -0.2%
19.69
US$61,649 		3,131 -0.2% 19.69 US$61,649
2023-05-15 2023-05-11 S Sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
15,000 -0.9%
20.71
US$310,650 		15,000 -0.9% 20.71 US$310,650
2023-05-11 2023-05-11 PrS Proposed sale
3.4
Tarriff Scott

CEO and President
60,000
20.83
US$1,250,000 		60,000 20.83 US$1,250,000
2022-09-08 2022-09-06 S Sale
2.2
Edlin Richard A.
Non-Executive Director
6,800 -23.1%
30.99
US$210,732 		6,800 -23.1% 30.99 US$210,732
2019-10-28 2019-10-25 PlS Planned sale
3.3
Hudson Executive Capital LP
15,437 -2.1%
63.57
US$981,302 		15,437 -2.1% 63.57 US$981,302
2019-10-28 2019-10-24 PlS Planned sale
3.3
Hudson Executive Capital LP
1,494 -0.2%
62.53
US$93,412 		1,494 -0.2% 62.53 US$93,412
2019-10-23 2019-10-23 PlS Planned sale
3.3
Hudson Executive Capital LP
200 -0.0%
62.58
US$12,516 		200 -0.0% 62.58 US$12,516
2019-10-23 2019-10-22 PlS Planned sale
3.3
Hudson Executive Capital LP
6,567 -0.9%
62.68
US$411,618 		6,567 -0.9% 62.68 US$411,618
2019-10-23 2019-10-21 PlS Planned sale
3.3
Hudson Executive Capital LP
3,849 -0.5%
62.56
US$240,791 		3,849 -0.5% 62.56 US$240,791
2019-10-18 2019-10-18 PlS Planned sale
3.3
Hudson Executive Capital LP
1,600 -0.2%
62.61
US$100,174 		1,600 -0.2% 62.61 US$100,174
2019-10-18 2019-10-17 PlS Planned sale
3.3
Hudson Executive Capital LP
13,842 -1.8%
62.58
US$866,196 		13,842 -1.8% 62.58 US$866,196
2019-10-18 2019-10-16 PlS Planned sale
3.3
Hudson Executive Capital LP
102 -0.0%
62.50
US$6,375 		102 -0.0% 62.50 US$6,375
2019-10-15 2019-10-15 PlS Planned sale
3.3
Hudson Executive Capital LP
3,909 -0.5%
62.63
US$244,836 		3,909 -0.5% 62.63 US$244,836
2019-10-15 2019-10-11 PlS Planned sale
3.3
Hudson Executive Capital LP
16,300 -2.0%
60.39
US$984,419 		16,300 -2.0% 60.39 US$984,419
2019-10-15 2019-10-10 PlS Planned sale
3.3
Hudson Executive Capital LP
7,829 -1.0%
60.16
US$471,002 		7,829 -1.0% 60.16 US$471,002
2019-10-09 2019-10-08 PlS Planned sale
3.3
Hudson Executive Capital LP
1,558 -0.2%
60.03
US$93,520 		1,558 -0.2% 60.03 US$93,520
2019-10-09 2019-10-07 PlS Planned sale
3.3
Hudson Executive Capital LP
4,901 -0.6%
60.11
US$294,600 		4,901 -0.6% 60.11 US$294,600
2019-09-19 2019-09-17 PlS Planned sale
3.3
Hudson Executive Capital LP
100 -0.0%
60.00
US$6,000 		100 -0.0% 60.00 US$6,000
2019-09-13 2019-09-12 PlS Planned sale
3.3
Hudson Executive Capital LP
200 -0.0%
60.07
US$12,014 		200 -0.0% 60.07 US$12,014
2019-09-13 2019-09-11 PlS Planned sale
3.3
Hudson Executive Capital LP
1,112 -0.1%
60.06
US$66,785 		1,112 -0.1% 60.06 US$66,785
2019-05-13 2019-05-10 S Sale
2.5
Braunstein Douglas L
100,000 -11.0%
56.14
US$5,614,000 		100,000 -11.0% 56.14 US$5,614,000
2019-05-13 2019-05-09 S Sale
2.5
Braunstein Douglas L
59,223 -6.1%
57.95
US$3,431,973 		59,223 -6.1% 57.95 US$3,431,973
2019-04-03 2019-04-01 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
24,975 -1.6%
50.15
US$1,252,496 		24,975 -1.6% 50.15 US$1,252,496
2019-03-04 2019-03-01 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
12,428 -0.8%
51.81
US$643,895 		12,428 -0.8% 51.81 US$643,895
2019-03-04 2019-03-01 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
12,000 -0.8%
50.51
US$606,120 		12,000 -0.8% 50.51 US$606,120
2019-02-04 2019-02-01 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
900 -0.1%
42.30
US$38,070 		900 -0.1% 42.30 US$38,070
2019-02-04 2019-02-01 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
29,185 -1.8%
41.52
US$1,211,761 		29,185 -1.8% 41.52 US$1,211,761
2019-01-04 2019-01-03 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
302 -0.0%
40.57
US$12,252 		302 -0.0% 40.57 US$12,252
2019-01-04 2019-01-03 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
5,670 -0.4%
39.70
US$225,099 		5,670 -0.4% 39.70 US$225,099
2019-01-04 2019-01-03 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
10,597 -0.7%
39.04
US$413,707 		10,597 -0.7% 39.04 US$413,707
2019-01-04 2019-01-02 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
8,500 -0.6%
40.03
US$340,255 		8,500 -0.6% 40.03 US$340,255
2019-01-04 2019-01-02 PlS Planned sale
3.4
Tarriff Scott

CEO

Executive Director Large shareholder
6,500 -0.4%
39.30
US$255,450 		6,500 -0.4% 39.30 US$255,450
2018-03-07 2018-03-06 S Sale FLAUM SANDER A Non-Executive Director
2,340 -17.1%
53.94
US$126,220 		2,340 -17.1% 53.94 US$126,220
2017-08-16 2017-08-16 B Purchase Meyers Pete A.

Chief Financial Officer
350 +100.0%
55.45
US$19,406 		350 +100.0% 55.45 US$19,406
2017-08-11 2017-08-09 B Purchase Braunstein Douglas L
1,584 +0.2%
50.09
US$79,338 		1,584 +0.2% 50.09 US$79,338
2017-08-11 2017-08-09 B Purchase Braunstein Douglas L
15,206 +1.6%
49.21
US$748,258 		15,206 +1.6% 49.21 US$748,258
2017-08-11 2017-08-09 B Purchase Braunstein Douglas L
3,610 +0.4%
48.06
US$173,490 		3,610 +0.4% 48.06 US$173,490
2017-06-12 2017-06-12 B Purchase Meyers Pete A.

Chief Financial Officer
350 +inf%
71.49
US$25,021 		350 +inf% 71.49 US$25,021
2017-05-19 2017-05-19 B Purchase Pernock David

Pres. & Chief Comm. Officer

Officer
255 +35.9%
79.69
US$20,321 		255 +35.9% 79.69 US$20,321
2017-05-16 2017-05-16 B Purchase Pernock David

Pres. & Chief Comm. Officer

Officer
200 +39.1%
82.24
US$16,448 		200 +39.1% 82.24 US$16,448
2017-04-27 2017-04-25 S Sale ProQuest Investments IV, L.P. Large shareholder
2,961 -30.4%
89.09
US$263,795 		2,961 -30.4% 89.09 US$263,795
2017-04-27 2017-04-25 S Sale ProQuest Investments IV, L.P. Large shareholder
51,219 -84.0%
88.34
US$4,524,686 		51,219 -84.0% 88.34 US$4,524,686
2017-04-03 2017-04-03 S Sale ProQuest Investments IV, L.P. Large shareholder
61,420 -1.7%
83.13
US$5,105,845 		61,420 -1.7% 83.13 US$5,105,845
2017-04-03 2017-03-31 S Sale ProQuest Investments IV, L.P. Large shareholder
23,689 -0.6%
83.02
US$1,966,661 		23,689 -0.6% 83.02 US$1,966,661
2017-04-03 2017-03-30 S Sale ProQuest Investments IV, L.P. Large shareholder
6,223 -0.2%
83.00
US$516,509 		6,223 -0.2% 83.00 US$516,509
2017-03-29 2017-03-29 S Sale ProQuest Investments IV, L.P. Large shareholder
1,600 -6.4%
83.01
US$132,816 		1,600 -6.4% 83.01 US$132,816
2017-03-29 2017-03-29 S Sale ProQuest Investments IV, L.P. Large shareholder
500 -6.9%
83.01
US$41,505 		500 -6.9% 83.01 US$41,505
2017-03-29 2017-03-29 S Sale ProQuest Investments IV, L.P. Large shareholder
58,755 -1.6%
83.01
US$4,877,253 		58,755 -1.6% 83.01 US$4,877,253
2017-03-29 2017-03-28 S Sale ProQuest Investments IV, L.P. Large shareholder
6,182 -0.2%
83.02
US$513,230 		6,182 -0.2% 83.02 US$513,230
2017-03-29 2017-03-27 S Sale ProQuest Investments IV, L.P. Large shareholder
1,300 -5.0%
83.00
US$107,900 		1,300 -5.0% 83.00 US$107,900
2017-03-29 2017-03-27 S Sale ProQuest Investments IV, L.P. Large shareholder
400 -5.2%
83.00
US$33,200 		400 -5.2% 83.00 US$33,200
2017-03-29 2017-03-27 S Sale ProQuest Investments IV, L.P. Large shareholder
37,731 -1.0%
83.00
US$3,131,673 		37,731 -1.0% 83.00 US$3,131,673
2017-03-24 2017-03-23 S Sale Krill Steven L.

EVP & Chief Scientific Officer
7,025 -100.0%
82.06
US$576,489 		7,025 -100.0% 82.06 US$576,489
2017-03-23 2017-03-23 S Sale ProQuest Investments IV, L.P. Large shareholder
700 -0.0%
83.01
US$58,107 		700 -0.0% 83.01 US$58,107
2017-03-24 2017-03-22 S Sale Krill Steven L.

EVP & Chief Scientific Officer
7,100 -100.0%
80.09
US$568,641 		7,100 -100.0% 80.09 US$568,641
2017-03-22 2017-03-22 B Purchase Edlin Richard A.
6,000 +25.6%
79.44
US$476,640 		6,000 +25.6% 79.44 US$476,640
2017-03-23 2017-03-21 S Sale ProQuest Investments IV, L.P. Large shareholder
500 -0.0%
83.10
US$41,550 		500 -0.0% 83.10 US$41,550
2017-03-21 2017-03-21 B Purchase Pernock David

Pres. & Chief Comm. Officer
61 +13.6%
83.98
US$5,123 		61 +13.6% 83.98 US$5,123
2017-03-20 2017-03-20 S Sale ProQuest Investments IV, L.P. Large shareholder
51,883 -1.4%
82.10
US$4,259,594 		51,883 -1.4% 82.10 US$4,259,594
2017-03-20 2017-03-17 S Sale ProQuest Investments IV, L.P. Large shareholder
38,997 -1.0%
82.01
US$3,198,144 		38,997 -1.0% 82.01 US$3,198,144
2017-03-20 2017-03-16 S Sale ProQuest Investments IV, L.P. Large shareholder
9,120 -0.2%
82.08
US$748,570 		9,120 -0.2% 82.08 US$748,570
2017-03-10 2017-03-09 B Purchase Pernock David

Pres. & Chief Comm. Officer
450 +inf%
77.84
US$35,028 		450 +inf% 77.84 US$35,028
Explore more

More insider trading research around Eagle Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America